These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19094060)

  • 61. Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways.
    Velier J; Kim M; Schwarz C; Kim TW; Sapp E; Chase K; Aronin N; DiFiglia M
    Exp Neurol; 1998 Jul; 152(1):34-40. PubMed ID: 9682010
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Huntington's disease and mitochondrial DNA deletions: event or regular mechanism for mutant huntingtin protein and CAG repeats expansion?!
    Banoei MM; Houshmand M; Panahi MS; Shariati P; Rostami M; Manshadi MD; Majidizadeh T
    Cell Mol Neurobiol; 2007 Nov; 27(7):867-75. PubMed ID: 17952586
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA.
    Hu J; Matsui M; Corey DR
    Ann N Y Acad Sci; 2009 Sep; 1175():24-31. PubMed ID: 19796074
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.
    Hu J; Liu J; Corey DR
    Chem Biol; 2010 Nov; 17(11):1183-8. PubMed ID: 21095568
    [TBL] [Abstract][Full Text] [Related]  

  • 65. RNA toxicity induced by expanded CAG repeats in Huntington's disease.
    Martí E
    Brain Pathol; 2016 Nov; 26(6):779-786. PubMed ID: 27529325
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability.
    Kaminosono S; Saito T; Oyama F; Ohshima T; Asada A; Nagai Y; Nukina N; Hisanaga S
    J Neurosci; 2008 Aug; 28(35):8747-55. PubMed ID: 18753376
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin.
    Her LS; Goldstein LS
    J Neurosci; 2008 Dec; 28(50):13662-72. PubMed ID: 19074039
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
    Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
    Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs.
    Hu J; Liu J; Narayanannair KJ; Lackey JG; Kuchimanchi S; Rajeev KG; Manoharan M; Swayze EE; Lima WF; Prakash TP; Xiang Q; Martinez C; Corey DR
    Biochemistry; 2014 Jul; 53(28):4510-8. PubMed ID: 24981774
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CAG expansion affects the expression of mutant Huntingtin in the Huntington's disease brain.
    Aronin N; Chase K; Young C; Sapp E; Schwarz C; Matta N; Kornreich R; Landwehrmeyer B; Bird E; Beal MF
    Neuron; 1995 Nov; 15(5):1193-201. PubMed ID: 7576661
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.
    Borrell-Pagès M; Zala D; Humbert S; Saudou F
    Cell Mol Life Sci; 2006 Nov; 63(22):2642-60. PubMed ID: 17041811
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India.
    Pramanik S; Basu P; Gangopadhaya PK; Sinha KK; Jha DK; Sinha S; Das SK; Maity BK; Mukherjee SC; Roychoudhuri S; Majumder PP; Bhattacharyya NP
    Eur J Hum Genet; 2000 Sep; 8(9):678-82. PubMed ID: 10980573
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Large-scale RNA interference screening in mammalian cells identifies novel regulators of mutant huntingtin aggregation.
    Yamanaka T; Wong HK; Tosaki A; Bauer PO; Wada K; Kurosawa M; Shimogori T; Hattori N; Nukina N
    PLoS One; 2014; 9(4):e93891. PubMed ID: 24705917
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Huntingtin contains a highly conserved nuclear export signal.
    Xia J; Lee DH; Taylor J; Vandelft M; Truant R
    Hum Mol Genet; 2003 Jun; 12(12):1393-403. PubMed ID: 12783847
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
    Bithell A; Johnson R; Buckley NJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pathogenic mechanisms in Huntington's disease.
    Jones L; Hughes A
    Int Rev Neurobiol; 2011; 98():373-418. PubMed ID: 21907095
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.
    Cooper JK; Schilling G; Peters MF; Herring WJ; Sharp AH; Kaminsky Z; Masone J; Khan FA; Delanoy M; Borchelt DR; Dawson VL; Dawson TM; Ross CA
    Hum Mol Genet; 1998 May; 7(5):783-90. PubMed ID: 9536081
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Replacement of huntingtin exon 1 by trans-splicing.
    Rindt H; Yen PF; Thebeau CN; Peterson TS; Weisman GA; Lorson CL
    Cell Mol Life Sci; 2012 Dec; 69(24):4191-204. PubMed ID: 22814437
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.